Related Experiment Video
Updated: May 2, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
21.0K
[Drug-drug interactions: interactions between xenobiotics]
1Klinische Pharmakologie am Lehrstuhl mit Poliklinik für Psychiatrie und Psychotherapie, Universität Regensburg, Universitätsstr. 84, 93053, Regensburg, Deutschland, ekkehard.haen@klinik.uni-regensburg.de.
Der Nervenarzt
|March 13, 2014
Summary
Drug-drug interactions (DDIs) are common and unavoidable. Physicians must manage, not just avoid, these interactions using classification systems and resources like online databases and drug information services.
Area of Science:
- Pharmacology
- Clinical Medicine
- Medical Education
Context:
- Drug-drug interactions (DDIs) are a significant concern in continuous medical education (CME) and routine medical practice.
- Physicians often fear malpractice due to DDIs, which can involve not only drugs but also food and other xenobiotics.
- Managing DDIs is a critical aspect of patient care, requiring careful consideration beyond simple avoidance.
Purpose:
- To provide physicians with a framework for assessing and managing drug-drug interactions.
- To introduce a classification system (PD1-PD4, PK1-PK3) to aid in risk assessment of potential interactions.
- To highlight the importance of utilizing available resources like online databases and drug information services.
Summary:
- DDIs are an inherent part of medical practice, necessitating a proactive management approach rather than solely avoidance.
- A proposed classification system can serve as a checklist for physicians to evaluate interaction risks for individual patients.
- Pharmacokinetic interactions can be effectively managed through therapeutic drug monitoring (TDM), and collaboration with drug information services is encouraged.
Impact:
- Empowers physicians to confidently manage drug-drug interactions, reducing patient risk and potential malpractice concerns.
- Enhances clinical decision-making by providing structured tools for interaction assessment.
- Promotes a collaborative approach to patient care by encouraging the use of expert resources and information services.
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
813
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
813
01:30Drug toxicity: Drug–Drug Interaction
423
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
423
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
695
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
695
01:30Combined Effects of Drugs: Antagonism
11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K
01:24Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
01:16Drug toxicity: Idiosyncratic Reactions
220
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220